You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Advances in GLP-1 treatment: focus on oral semaglutide
|
|---|---|
| Published in |
Diabetology & Metabolic Syndrome, September 2021
|
| DOI | 10.1186/s13098-021-00713-9 |
| Pubmed ID | |
| Authors |
Freddy G. Eliaschewitz, Luis Henrique Canani |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Uruguay | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 6 | 12% |
| Student > Bachelor | 3 | 6% |
| Student > Master | 3 | 6% |
| Student > Ph. D. Student | 3 | 6% |
| Unspecified | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 30 | 58% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 17% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Unspecified | 2 | 4% |
| Philosophy | 1 | 2% |
| Other | 4 | 8% |
| Unknown | 30 | 58% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2022.
All research outputs
#7,504,088
of 23,576,969 outputs
Outputs from Diabetology & Metabolic Syndrome
#228
of 710 outputs
Outputs of similar age
#148,957
of 430,868 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#9
of 26 outputs
Altmetric has tracked 23,576,969 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 710 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,868 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.